1. Home
  2. HURA vs SGA Comparison

HURA vs SGA Comparison

Compare HURA & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$1.99

Market Cap

87.5M

Sector

N/A

ML Signal

HOLD

Logo Saga Communications Inc. (FL)

SGA

Saga Communications Inc. (FL)

N/A

Current Price

$12.05

Market Cap

73.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
HURA
SGA
Founded
2009
1986
Country
United States
United States
Employees
19
N/A
Industry
Broadcasting
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
87.5M
73.7M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
HURA
SGA
Price
$1.99
$12.05
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
800.3K
9.3K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
8.36%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$124,829,000.00
Revenue This Year
N/A
$6.74
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.65
52 Week Low
$0.41
$10.68
52 Week High
$4.41
$14.27

Technical Indicators

Market Signals
Indicator
HURA
SGA
Relative Strength Index (RSI) 63.26 60.06
Support Level $1.56 $11.27
Resistance Level $2.20 $11.99
Average True Range (ATR) 0.20 0.32
MACD -0.02 0.08
Stochastic Oscillator 66.45 95.45

Price Performance

Historical Comparison
HURA
SGA

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

Share on Social Networks: